User Fee Reauthorization Act will spur FDA pilot programs
FDA User Fee Reauthorization legislation provides insurance for continuity in medical product review programs and supports financial transparency.
Archives for October 3, 2022
US BARDA contracts onshore manufacture of nerve agent treatment
Marinus will receive funds from BARDA to support the development of intravenous ganaxolone for the treatment of refractory status epilepticus.
Pfizer makes 6m oral COVID treatments available to lower income countries
The treatments will be provided to The Global Fund, which will allow 132 countries to receive the oral COVID-19 treatment, Paxlovid.
Swimming algae microrobots deliver antibiotic nanoparticles to lungs
Researchers from the University of California San Diego tested whether algae could improve the delivery of antibiotics to treat cases of bacterial pneumonia.
How to expedite your clinical trial reporting: The pivotal role of AI
Paid for and in partnership with Yseop
A premier resource of AI for life sciences, pioneers can save up to 30% of time generating crucial reports for regulatory submission.